MEF2C deletions and mutations versus duplications: A clinical comparison

Francesca Novara, Ambra Rizzo, Gloria Bedini, Vita Girgenti, Silvia Esposito, Chiara Pantaleoni, Roberto Ciccone, Francesca L. Sciacca, Valentina Achille, Erika Della Mina, Simone Gana, Orsetta Zuffardi, Margherita Estienne

Research output: Contribution to journalArticlepeer-review


5q14.3 deletions including the MEF2C gene have been identified to date using genomic arrays in patients with severe developmental delay or intellectual disability, stereotypic behavior, epilepsy, cerebral malformations and a facial gestalt not really distinctive though characterized by broad and/or high, bulging forehead, upslanting palpebral fissures, flat nasal root and bridge, small, upturned nose, hypotonic small mouth resulting in cupid bow/tented upper lip. MEF2C mutations have been also identified in patients with overlapping phenotype so that it is considered the gene responsible for the 5q14.3 deletion syndrome. To date, one single duplication including MEF2C has been reported in a patient with intellectual disability but its clinical significance remains uncertain also because of the large size of the imbalance. Here we present two further patients with 5q14.3 duplications including MEF2C. Their phenotype indeed suggest the pathogenic effect of the MEF2C duplication although other duplicated genes also brain expressed might contribute to the clinical features. In none of them a clear-cut syndrome can be identified. A comparison between MEF2C deleted/mutated and duplicated patients is also presented.

Original languageEnglish
Pages (from-to)260-265
Number of pages6
JournalEuropean Journal of Medical Genetics
Issue number5
Publication statusPublished - 2013


  • 5q14.3 microduplication syndrome
  • Array-CGH
  • MEF2C

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)


Dive into the research topics of 'MEF2C deletions and mutations versus duplications: A clinical comparison'. Together they form a unique fingerprint.

Cite this